Skip to main content
Erschienen in: Clinical Rheumatology 11/2016

25.04.2016 | Original Article

Evaluation of tool-like receptor-2 and 4 and interleukin-6 gene expressions in Turkish rheumatoid arthritis patients

verfasst von: Betul Eser, Nilay Sahin

Erschienen in: Clinical Rheumatology | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Rheumatoid arthritis (RA) is a progressive inflammatory disease. Although the etiology and pathogenesis of RA are not known well, genetic and environmental factors are proposed to initiate an autoimmune process. We aimed to investigate mRNA expression levels of Toll-like receptor-2 (TLR-2), TLR-4, and interleukin-6 (IL-6) genes in RA disease. This study was conducted with 50 patients who were diagnosed with RA according to the American College of Rheumatology classification criteria for RA and 50 age-matched healthy control individuals who did not have any joint diseases and autoimmune diseases. We collected whole blood from all participants and analyzed expression of TLR-2, TLR-4, and IL-6 genes at mRNA level using real-time qPCR. TLR-2 expression was detected to increase 3.8-fold and IL-6 expression was detected to increase 6.8-fold in RA patients compared to healthy controls. No difference was found between patient and control groups with regard to TLR-4 expression. Overexpression of TLR-2 and IL-6 may be responsible for RA pathogenesis. Inhibition of both TLR and IL signaling pathways may prevent joint inflammation and destruction.
Literatur
1.
Zurück zum Zitat Radstake TR, Roelofs MF, Jenniskens YM, Oppers-Walgreen B, van Riel PL, Barrera P, Joosten LA, van den Berg WB (2004) Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis Rheum 50(12):3856–3865. doi:10.1002/art.20678 PubMedCrossRef Radstake TR, Roelofs MF, Jenniskens YM, Oppers-Walgreen B, van Riel PL, Barrera P, Joosten LA, van den Berg WB (2004) Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis Rheum 50(12):3856–3865. doi:10.​1002/​art.​20678 PubMedCrossRef
2.
Zurück zum Zitat Ospelt C, Brentano F, Rengel Y, Stanczyk J, Kolling C, Tak PP, Gay RE, Gay S, Kyburz D (2008) Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum 58(12):3684–3692. doi:10.1002/art.24140 PubMedCrossRef Ospelt C, Brentano F, Rengel Y, Stanczyk J, Kolling C, Tak PP, Gay RE, Gay S, Kyburz D (2008) Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum 58(12):3684–3692. doi:10.​1002/​art.​24140 PubMedCrossRef
3.
Zurück zum Zitat Foster W, Carruthers D, Lip GY, Blann AD (2010) Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment. J Thromb Thrombolysis 29(4):437–442. doi:10.1007/s11239-009-0370-y PubMedCrossRef Foster W, Carruthers D, Lip GY, Blann AD (2010) Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment. J Thromb Thrombolysis 29(4):437–442. doi:10.​1007/​s11239-009-0370-y PubMedCrossRef
6.
Zurück zum Zitat Chovanova L, Vlcek M, Krskova K, Penesova A, Radikova Z, Rovensky J, Cholujova D, Sedlak J, Imrich R (2013) Increased production of IL-6 and IL-17 in lipopolysaccharide-stimulated peripheral mononuclears from patients with rheumatoid arthritis. Gen Physiol Biophys 32(3):395–404. doi:10.4149/gpb_2013043 PubMedCrossRef Chovanova L, Vlcek M, Krskova K, Penesova A, Radikova Z, Rovensky J, Cholujova D, Sedlak J, Imrich R (2013) Increased production of IL-6 and IL-17 in lipopolysaccharide-stimulated peripheral mononuclears from patients with rheumatoid arthritis. Gen Physiol Biophys 32(3):395–404. doi:10.​4149/​gpb_​2013043 PubMedCrossRef
14.
Zurück zum Zitat Kokkonen H, Soderstrom I, Rocklov J, Hallmans G, Lejon K, Rantapaa Dahlqvist S (2010) Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum 62(2):383–391. doi:10.1002/art.27186 PubMed Kokkonen H, Soderstrom I, Rocklov J, Hallmans G, Lejon K, Rantapaa Dahlqvist S (2010) Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum 62(2):383–391. doi:10.​1002/​art.​27186 PubMed
15.
Zurück zum Zitat Wei ST, Sun YH, Zong SH, Xiang YB (2015) Serum levels of IL-6 and TNF-alpha may correlate with activity and severity of rheumatoid arthritis. Med Sci Monit 21:4030–4038PubMedPubMedCentralCrossRef Wei ST, Sun YH, Zong SH, Xiang YB (2015) Serum levels of IL-6 and TNF-alpha may correlate with activity and severity of rheumatoid arthritis. Med Sci Monit 21:4030–4038PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Jaen O, Petit-Teixeira E, Kirsten H, Ahnert P, Semerano L, Pierlot C, Cornelis F, Boissier MC, Falgarone G, European Consortium on Rheumatoid Arthritis F (2009) No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis. Arthritis Res Ther 11(1):R5. doi:10.1186/ar2589 PubMedPubMedCentralCrossRef Jaen O, Petit-Teixeira E, Kirsten H, Ahnert P, Semerano L, Pierlot C, Cornelis F, Boissier MC, Falgarone G, European Consortium on Rheumatoid Arthritis F (2009) No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis. Arthritis Res Ther 11(1):R5. doi:10.​1186/​ar2589 PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Coenen MJ, Enevold C, Barrera P, Schijvenaars MM, Toonen EJ, Scheffer H, Padyukov L, Kastbom A, Klareskog L, Barton A, Kievit W, Rood MJ, Jansen TL, Swinkels D, van Riel PL, Franke B, Bendtzen K, Radstake TR (2010) Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome. PLoS One 5(12):e14326. doi:10.1371/journal.pone.0014326 PubMedPubMedCentralCrossRef Coenen MJ, Enevold C, Barrera P, Schijvenaars MM, Toonen EJ, Scheffer H, Padyukov L, Kastbom A, Klareskog L, Barton A, Kievit W, Rood MJ, Jansen TL, Swinkels D, van Riel PL, Franke B, Bendtzen K, Radstake TR (2010) Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome. PLoS One 5(12):e14326. doi:10.​1371/​journal.​pone.​0014326 PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Etem EO, Elyas H, Ozgocmen S, Yildirim A, Godekmerdan A (2011) The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients. Rheumatol Int 31(10):1369–1374. doi:10.1007/s00296-010-1472-8 PubMedCrossRef Etem EO, Elyas H, Ozgocmen S, Yildirim A, Godekmerdan A (2011) The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients. Rheumatol Int 31(10):1369–1374. doi:10.​1007/​s00296-010-1472-8 PubMedCrossRef
20.
Zurück zum Zitat Kim KW, Cho ML, Lee SH, Oh HJ, Kang CM, Ju JH, Min SY, Cho YG, Park SH, Kim HY (2007) Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation. Immunol Lett 110(1):54–64. doi:10.1016/j.imlet.2007.03.004 PubMedCrossRef Kim KW, Cho ML, Lee SH, Oh HJ, Kang CM, Ju JH, Min SY, Cho YG, Park SH, Kim HY (2007) Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation. Immunol Lett 110(1):54–64. doi:10.​1016/​j.​imlet.​2007.​03.​004 PubMedCrossRef
21.
22.
Zurück zum Zitat Lorenz W, Buhrmann C, Mobasheri A, Lueders C, Shakibaei M (2013) Bacterial lipopolysaccharides form procollagen-endotoxin complexes that trigger cartilage inflammation and degeneration: implications for the development of rheumatoid arthritis. Arthritis Res Ther 15(5):R111. doi:10.1186/ar4291 PubMedPubMedCentralCrossRef Lorenz W, Buhrmann C, Mobasheri A, Lueders C, Shakibaei M (2013) Bacterial lipopolysaccharides form procollagen-endotoxin complexes that trigger cartilage inflammation and degeneration: implications for the development of rheumatoid arthritis. Arthritis Res Ther 15(5):R111. doi:10.​1186/​ar4291 PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Kowalski ML, Wolska A, Grzegorczyk J, Hilt J, Jarzebska M, Drobniewski M, Synder M, Kurowski M (2008) Increased responsiveness to toll-like receptor 4 stimulation in peripheral blood mononuclear cells from patients with recent onset rheumatoid arthritis. Mediators Inflamm 2008:132732. doi:10.1155/2008/132732 PubMedPubMedCentralCrossRef Kowalski ML, Wolska A, Grzegorczyk J, Hilt J, Jarzebska M, Drobniewski M, Synder M, Kurowski M (2008) Increased responsiveness to toll-like receptor 4 stimulation in peripheral blood mononuclear cells from patients with recent onset rheumatoid arthritis. Mediators Inflamm 2008:132732. doi:10.​1155/​2008/​132732 PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Kyburz D, Rethage J, Seibl R, Lauener R, Gay RE, Carson DA, Gay S (2003) Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling. Arthritis Rheum 48(3):642–650. doi:10.1002/art.10848 PubMedCrossRef Kyburz D, Rethage J, Seibl R, Lauener R, Gay RE, Carson DA, Gay S (2003) Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling. Arthritis Rheum 48(3):642–650. doi:10.​1002/​art.​10848 PubMedCrossRef
25.
Zurück zum Zitat Ohashi K, Burkart V, Flohe S, Kolb H (2000) Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164(2):558–561PubMedCrossRef Ohashi K, Burkart V, Flohe S, Kolb H (2000) Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164(2):558–561PubMedCrossRef
26.
Zurück zum Zitat Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC (2002) Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195(1):99–111PubMedPubMedCentralCrossRef Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC (2002) Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195(1):99–111PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Goldstein RS, Bruchfeld A, Yang L, Qureshi AR, Gallowitsch-Puerta M, Patel NB, Huston BJ, Chavan S, Rosas-Ballina M, Gregersen PK, Czura CJ, Sloan RP, Sama AE, Tracey KJ (2007) Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol Med 13(3-4):210–215. doi:10.2119/2006-00108.Goldstein PubMedPubMedCentralCrossRef Goldstein RS, Bruchfeld A, Yang L, Qureshi AR, Gallowitsch-Puerta M, Patel NB, Huston BJ, Chavan S, Rosas-Ballina M, Gregersen PK, Czura CJ, Sloan RP, Sama AE, Tracey KJ (2007) Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol Med 13(3-4):210–215. doi:10.​2119/​2006-00108.​Goldstein PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Brentano F, Schorr O, Gay RE, Gay S, Kyburz D (2005) RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis Rheum 52(9):2656–2665. doi:10.1002/art.21273 PubMedCrossRef Brentano F, Schorr O, Gay RE, Gay S, Kyburz D (2005) RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis Rheum 52(9):2656–2665. doi:10.​1002/​art.​21273 PubMedCrossRef
Metadaten
Titel
Evaluation of tool-like receptor-2 and 4 and interleukin-6 gene expressions in Turkish rheumatoid arthritis patients
verfasst von
Betul Eser
Nilay Sahin
Publikationsdatum
25.04.2016
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 11/2016
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3282-1

Weitere Artikel der Ausgabe 11/2016

Clinical Rheumatology 11/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.